The IDMP standards aim to harmonise how pharmaceutical products and substances are described globally. But how will that benefit patients and who will make sure the standards are properly implemented? Uppsala Monitoring Centre’s Malin Fladvad and Olle Lagerlund discuss the advantages and challenges of this global standardisation effort in the Drug Safety Matters podcast.